Most Recent
Bayer has lost its battle to protect top-selling blood thinner Xarelto from generic competition, with the Full Court finding two patents for the drug are invalid.
An environmental group has lost a court challenge to controlled burns in the state’s Strathbogie Forest, despite arguing they would destroy the habitat of the endangered Southern greater glider.
Infant formula company Care A2 has found new lawyers as trial begins in a trade mark dispute with rival a2 Milk.
The former CEO of fintech iSignthis would need a loan to pay a $1.5 million penalty sought by the corporate regulator for breaches of directors duties, a court has heard.
Care A2 is set to miss the trial in its trade mark fight with rival A2 Milk after the baby formula company was ditched by its lawyers at Ashurst days ago.
Bix Six firm Ashurst has dropped Care A2 as a client on the eve of trial in the dairy company's long-running battle to quash rival A2 Milk's trade marks.
A court has tossed claims against ASIC by the former boss of investment fund Blue Sky, describing the allegations as scandalous and untenable.
A class action against McDonald’s alleging workers were not given mandatory rest breaks has “gone backwards” after the fast food giant withdrew previously agreed facts, a court has heard.
A class action over S&P’s rosy ratings on risky financial products faces a preliminary fight over the relevance of expert evidence that seeks to prove fraud on the part of the ratings agency.
In a first, EnergyAustralia has been ordered to pay $14 million for breaching the Electricity Retail Code by misleading customers about prices.